학술논문
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial
Document Type
Article
Author
Chu, Kai; Bi, Zhao-Feng; Huang, Wei-Jin; Li, Ya-Fei; Zhang, Li; Yang, Chang-Lin; Jiang, Han-Min; Zang, Xia; Chen, Qi; Liu, Dong-Lin; Pan, Hong-Xing; Huang, Yue; Zheng, Feng-Zhu; Zhang, Qiu-Fen; Sun, Guang; Su, Ying-Ying; Huang, Shou-Jie; Pan, Hui-Rong; Wu, Ting; Hu, Yue-Mei; Zhang, Jun; Zhu, Feng-Cai; Xia, Ning-Shao
Source
In The Lancet Regional Health - Western Pacific May 2023 34
Subject
Language
ISSN
2666-6065